Federal contract award
36C25226F0318
ANDEMBRY (GARADACIMAB-GXII) 200MG/1.2ML AUTO INJECTOR
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 252-NETWORK CONTRACT OFFICE 12 (36C252) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79721D0249 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $85.5K |
| Current contract value | $85.5K |
| Potential contract value / ceiling | $85.5K |
| Start date | Jun 23, 2026 |
| Current end date | Jul 18, 2026 |
| Potential end date | Jul 18, 2026 |
| Latest award activity | Jun 23, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 23, 2026 | 0 | $85.5K | ANDEMBRY (GARADACIMAB-GXII) 200MG/1.2ML AUTO INJECTOR |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.